Founder of Isomorphic Labs aims to develop a drug in oncology, cardiovascular or neurodegeneration areas

Benzinga

New York

United States

Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases - Alphabet (NASDAQ:GOOGL), CRISPR Therapeutics (NASDAQ:CRSP)

An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.

Ad Fontes Media

Media Bias/Fact Check

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief executive officer.

All Sides

Bloomberg

Michael Bloomberg

The Vanguard Group

Howard Buffett

BlackRock

DeepMind Expects Clinical Trials for AI-Designed Drugs This Year

Financial Times

Nikkei Inc.

London

Greater London

England

United Kingdom

AI-developed drug will be in trials by year-end, says Google’s Hassabis

Nobel Prize winner Demis Hassabis thinks human trials will happen soon

The Register

DeepMind CEO expects we'll pop AI-generated pills in 2025

Nobel laureate and Google DeepMind CEO Demis Hassabis said Tuesday (Jan. 21) that he expects to see pharmaceutical drugs designed by artificial intelligence (AI) to be in clinical trials by the end of the year. During a fireside chat at the World Economic Forum in Davos, Switzerland, Hassabis said these drugs are being developed at Isomorphic Labs, a for-profit venture created by Google parent firm Alphabet in 2021 that was tasked to reinvent th…

PYMNTS.com

Google DeepMind CEO: AI-Designed Drugs Coming to Clinical Trials in 2025

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups race to turn algorithmic magic into actual treatments.
“We’ll hopefully have some AI-designed drugs in clinical tria

Amsterdam

Government of Amsterdam

North Holland

Netherlands

Europe accelerates AI drug discovery as DeepMind spinoff targets trials this year

Last Updated on January 22, 2025 by Editorial Team Author(s): Arunabh Bora Originally published on Towards AI. Using RAG with multi-representation indexing to get full context data from technical documents This member-only story is on us. Upgrade to access all of Medium. Image generated with Imagen 3 This article is inspired by a project I recently did, which was centered around fetching a lot of technical data from PDF documents (mostly tables,…

Towards AI — Multidisciplinary Science Journal

Accelerating Drug Approvals Using Advanced RAG

Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested Tuesday. . . .

technewstube.com

Google DeepMind CEO says 2025's the year we start popping pills AI helped invent

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested Tuesday. Speaking on a panel at the World Economic Forum in Davos, Hassabis, who also runs DeepMind drug-discovery spin-off Isomorphic Labs, said he expected to have “some AI-designed drugs in clinical trials by the end of the year… That’s the plan.” Isomorphic Labs has tried to speed up the …

Plato. Vertical Search. Ai. | PlatoAiStream. Data Intelligence. Vertical Search. Ai.

Google DeepMind CEO Says 2025's The Year We Start Popping Pills AI Helped Invent - Plato Data Intelligence

Nobel laureate and Google DeepMind CEO Demis Hassabis said Tuesday (Jan. 21) that he expects to see pharmaceutical drugs designed by artificial

AI-developed drug will be in trials by year-end, says Google’s Hassabis

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics